| Description |
1 online resource (401 pages) |
| Series |
Neurological Disease and Therapy |
|
Neurological disease and therapy.
|
| Contents |
Cover; Series Introduction; Preface; Contents; Contributors; Chapter 1. Movement Disorders, Phenomenology, and Differential Diagnosis; Chapter 2. Movement Disorders in Unmedicated Schizophrenia; Chapter 3. The Epidemiology of Tardive Dyskinesia; Chapter 4. Drug-Induced Parkinsonism; Chapter 5. Clinical Features and Management of Classic Tardive Dyskinesia, Tardive Myoclonus, Tardive Tremor, and Tardive Tourettism; Chapter 6. Acute and Tardive Dystonia; Chapter 7. Acute and Tardive Drug-Induced Akathisia; Chapter 8. Neuroleptic Malignant Syndrome |
|
Chapter 9. New Approaches to the Treatment of Dopamine Blocking Agent-Induced Movement DisordersChapter 10. Lithium-Induced Movement Disorders; Chapter 11. Movement Disorders Induced by Selective Serotonin Reuptake Inhibitors and Other Antidepressants; Chapter 12. Involuntary Movements Caused by Levodopa; Chapter 13. Pathophysiology of Levodopa and Dopamine Blocking Agent-Induced Movement Disorders; Chapter 14. Stimulant-Induced Movement Disorders; Chapter 15. Antiepileptic Drug-Induced Movement Disorders; Chapter 16. Other Drug-Induced Movement Disorders; Index; About the Editor |
| Summary |
Drug-Induced Movement Disorders rigorously analyzes established and emerging facts surrounding drug-induced dystonia, dyskinesia, akathisia, parkinsonism, and other acute and tardive movement disorders liable to result from medicinal use of dopamine blocking agents, antidepressants, levodopa, anticonvulsants, and other drugs-providing professionals effective tools for predicting, identifying, and proactively managing these often treatable, and frequently preventable, conditions |
| Notes |
Print version record |
| Form |
Electronic book
|
| ISBN |
9781135538323 |
|
1135538328 |
|
